Hematology Oncology Associates of Central New York-Liverpool — Liverpool, New York

Hematology Oncology Associates of Central New York-Liverpool is a clinical research site located in Liverpool, New York, United States 13088.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Central New York-Liverpool has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Lymphoma, Mantle Cell Lymphoma, Giant Cell Glioblastoma.

Sponsors: Eastern Cooperative Oncology Group, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Central New York-Liverpool?

Hematology Oncology Associates of Central New York-Liverpool has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Central New York-Liverpool conducted?

Hematology Oncology Associates of Central New York-Liverpool has 7 clinical trials on record, with 4 currently active. Their work covers Lymphoma, Mantle Cell Lymphoma, Giant Cell Glioblastoma.

Is Hematology Oncology Associates of Central New York-Liverpool accredited by Crixeo Health?

Yes — Hematology Oncology Associates of Central New York-Liverpool holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hematology Oncology Associates of Central New York-Liverpool?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.